Altered Growth and Envelope Properties of Polylysogens Containing Bacteriophage Lambda N-c I- Prophages

Int J Mol Sci. 2020 Feb 28;21(5):1667. doi: 10.3390/ijms21051667.

Abstract

The bacterial virus lambda (λ) is a temperate bacteriophage that can lysogenize host Escherichia coli (E. coli) cells. Lysogeny requires λ repressor, the cI gene product, which shuts off transcription of the phage genome. The λ N protein, in contrast, is a transcriptional antiterminator, required for expression of the terminator-distal genes, and thus, λ N mutants are growth-defective. When E. coli is infected with a λ double mutant that is defective in both N and cI (i.e., λN-cI-), at high multiplicities of 50 or more, it forms polylysogens that contain 20-30 copies of the λN-cI- genome integrated in the E. coli chromosome. Early studies revealed that the polylysogens underwent "conversion" to long filamentous cells that form tiny colonies on agar. Here, we report a large set of altered biochemical properties associated with this conversion, documenting an overall degeneration of the bacterial envelope. These properties reverted back to those of nonlysogenic E. coli as the metastable polylysogen spontaneously lost the λN-cI- genomes, suggesting that conversion is a direct result of the multiple copies of the prophage. Preliminary attempts to identify lambda genes that may be responsible for conversion ruled out several candidates, implicating a potentially novel lambda function that awaits further studies.

Keywords: Gram-negative; bacteriophage lambda; lipopolysaccharide; lysogenic conversion; membrane; polylysogen.

MeSH terms

  • Bacteriophage lambda / drug effects
  • Bacteriophage lambda / genetics
  • Bacteriophage lambda / growth & development*
  • Bacteriophage lambda / ultrastructure
  • Cytoplasm / drug effects
  • Cytoplasm / metabolism
  • Dactinomycin / pharmacology
  • Escherichia coli / virology
  • Genes, Viral
  • Lysogeny / drug effects
  • Lysogeny / physiology*
  • Membrane Proteins / metabolism
  • Models, Biological
  • Nalidixic Acid / pharmacology
  • Peptidoglycan / metabolism
  • Prophages / drug effects
  • Prophages / growth & development*
  • Prophages / ultrastructure
  • Viral Proteins / metabolism

Substances

  • Membrane Proteins
  • Peptidoglycan
  • Viral Proteins
  • Dactinomycin
  • Nalidixic Acid